AI accelerates search for new tuberculosis drug targets
Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and ...
News Medical on MSN2h
AI-based technology accelerates discovery of new tuberculosis drug candidates
Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and into the lungs, the pathogen that causes "TB" can lead to chronic cough, ...
Cash incentives and counseling could be key to improving TB treatment success rates
A new study has demonstrated that a combination of conditional cash transfers and TB counseling significantly improves treatment success rates and reduces loss to follow-up among TB patients in South ...
HealthDay on MSN10h
Three All-Oral Shortened Regimens Noninferior for Rifampin-Resistant TB
Three all-oral shortened regimens have noninferior efficacy compared with standard therapy for fluoroquinolone-susceptible, rifampin-resistant tuberculosis, according to a study published in the Jan.
AZoRobotics on MSN57m
New AI Platform Revolutionizes TB Drug Discovery by Analyzing Cell Images
A study reveals AI's role in identifying antimicrobial compounds for tuberculosis, enhancing drug development through innovative bacterial profiling techniques.
verywellhealth18h
A New 'Missile' Drug Is Approved To Treat the Most Common Breast Cancer Type
The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...